Q1 2026 · 13F-HR
Lunate Capital Ltdholdings as filed
Filed 2026-04-16 · accession 0001011438-26-000235
$120.4M
Reported value
6
Positions
2026-03-31
Period end
Holdings as filed
| CUSIP | Ticker | Issuer | Value | % port. | Shares | Class | Voting |
|---|---|---|---|---|---|---|---|
| 76155X100 | RVMD | REVOLUTION MEDICINES INC | $53.4M | 44.4% | 549,050 | Common | SOLE |
| 78781J109 | SAIL | SAILPOINT INC | $39.7M | 33.0% | 3,000,000 | Common | SOLE |
| 53566V106 | LINE | LINEAGE INC | $19.7M | 16.3% | 600,000 | Common | SOLE |
| 640979100 | NMRA | NEUMORA THERAPEUTICS INC. | $4.1M | 3.44% | 2,124,143 | Common | SOLE |
| 639193101 | NAVN | NAVAN INC | $2.6M | 2.20% | 200,000 | Common | SOLE |
| 76155X118 | RVMDW | REVOLUTION MEDICINES INC | $805,500 | 0.67% | 450,000 | Common | SOLE |
Source: SEC EDGAR · raw 13F holdings as filed. The Class column shows the option type when reported (Put/Call) or Common when the issuer's equity is held directly. 13F discloses long positions only.